Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Targeting of neoplastic progenitors as new therapeutic strategy in AML

Feb. 26, 2021

Bacterial protease takes on "undruggable" oncoprotein

Feb. 25, 2021

Salarius initiates expansion stage for phase I/II study of seclidemstat in Ewing sarcoma

Feb. 25, 2021

New PTPN11 inhibitors presented by Etern Biopharma

Feb. 25, 2021

Medshine Discovery synthesizes PARP-1 inhibitors

Feb. 25, 2021

Integral BioSciences divulges Chk1 inhibitors

Feb. 25, 2021

Australian researchers identify potential treatment for fatal brain cancer in children

Feb. 24, 2021

China NMPA accepts IND for JS-111

Feb. 24, 2021

Medshine Discovery synthesizes FGFR and VEGFR dual inhibitors

Feb. 24, 2021

Jinan University synthesizes new EGFR inhibitors

Feb. 24, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...